Sildenafil and diastolic dysfunction after acute myocardial infarction trial: rationale and design

Mads J Andersen, Finn Gustafsson, Christian Hassager, Lars Køber, Jacob E Møller

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Diastolic dysfunction following myocardial infarction is an important predictor of outcome, irrespective of left ventricular systolic function. Previous studies suggest that phosphordiesterase-5 inhibition has a favorable effect on the myocardium as well as on the pulmonary and systemic vasculature.
Original languageEnglish
JournalClincial Cardiology
Volume36
Issue number4
Pages (from-to)179-183
ISSN0160-9289
DOIs
Publication statusPublished - 2013

Fingerprint

Left Ventricular Function
Myocardium
Lung
Sildenafil Citrate

Cite this

Andersen, Mads J ; Gustafsson, Finn ; Hassager, Christian ; Køber, Lars ; Møller, Jacob E. / Sildenafil and diastolic dysfunction after acute myocardial infarction trial : rationale and design. In: Clincial Cardiology. 2013 ; Vol. 36, No. 4. pp. 179-183.
@article{f9aa9822ec424e1f8882d3a5dbc069f8,
title = "Sildenafil and diastolic dysfunction after acute myocardial infarction trial: rationale and design",
abstract = "Diastolic dysfunction following myocardial infarction is an important predictor of outcome, irrespective of left ventricular systolic function. Previous studies suggest that phosphordiesterase-5 inhibition has a favorable effect on the myocardium as well as on the pulmonary and systemic vasculature.",
author = "Andersen, {Mads J} and Finn Gustafsson and Christian Hassager and Lars K{\o}ber and M{\o}ller, {Jacob E}",
note = "{\circledC} 2013 Wiley Periodicals, Inc.",
year = "2013",
doi = "10.1002/clc.22103",
language = "English",
volume = "36",
pages = "179--183",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "Wiley Periodicals, Inc.",
number = "4",

}

Sildenafil and diastolic dysfunction after acute myocardial infarction trial : rationale and design. / Andersen, Mads J; Gustafsson, Finn; Hassager, Christian; Køber, Lars; Møller, Jacob E.

In: Clincial Cardiology, Vol. 36, No. 4, 2013, p. 179-183.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Sildenafil and diastolic dysfunction after acute myocardial infarction trial

T2 - rationale and design

AU - Andersen, Mads J

AU - Gustafsson, Finn

AU - Hassager, Christian

AU - Køber, Lars

AU - Møller, Jacob E

N1 - © 2013 Wiley Periodicals, Inc.

PY - 2013

Y1 - 2013

N2 - Diastolic dysfunction following myocardial infarction is an important predictor of outcome, irrespective of left ventricular systolic function. Previous studies suggest that phosphordiesterase-5 inhibition has a favorable effect on the myocardium as well as on the pulmonary and systemic vasculature.

AB - Diastolic dysfunction following myocardial infarction is an important predictor of outcome, irrespective of left ventricular systolic function. Previous studies suggest that phosphordiesterase-5 inhibition has a favorable effect on the myocardium as well as on the pulmonary and systemic vasculature.

U2 - 10.1002/clc.22103

DO - 10.1002/clc.22103

M3 - Journal article

C2 - 23450513

VL - 36

SP - 179

EP - 183

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 4

ER -